Wells Fargo & Company Initiates Coverage on Rocket Lab (NASDAQ:RKLB)

Wells Fargo & Company assumed coverage on shares of Rocket Lab (NASDAQ:RKLB) in a research report issued to clients and investors on Wednesday, Marketbeat reports. The brokerage set an “equal weight” rating and a $60.00 price target on the rocket manufacturer’s stock. Wells Fargo & Company‘s target price indicates a potential downside of 11.41% from the company’s current price.

Several other research analysts also recently weighed in on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rocket Lab in a report on Thursday, January 22nd. KeyCorp cut Rocket Lab from an “overweight” rating to a “sector weight” rating in a report on Thursday, January 15th. Zacks Research downgraded Rocket Lab from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 10th. Citizens Jmp reaffirmed a “market perform” rating on shares of Rocket Lab in a research note on Friday, February 27th. Finally, Clear Str upgraded Rocket Lab to a “strong-buy” rating in a research report on Wednesday, March 18th. Two investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Rocket Lab currently has an average rating of “Moderate Buy” and an average price target of $79.42.

Rocket Lab Stock Performance

RKLB opened at $67.73 on Wednesday. The firm has a market cap of $38.43 billion, a P/E ratio of -183.05 and a beta of 2.20. Rocket Lab has a 1-year low of $14.71 and a 1-year high of $99.58. The company has a 50 day simple moving average of $71.79 and a two-hundred day simple moving average of $64.83. The company has a debt-to-equity ratio of 0.10, a current ratio of 4.08 and a quick ratio of 3.61.

Insider Buying and Selling

In other Rocket Lab news, CEO Peter Beck sold 18,857 shares of Rocket Lab stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $69.59, for a total value of $1,312,258.63. Following the sale, the chief executive officer directly owned 884,085 shares in the company, valued at approximately $61,523,475.15. The trade was a 2.09% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Adam C. Spice sold 62,744 shares of the stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $69.59, for a total transaction of $4,366,354.96. Following the transaction, the chief financial officer directly owned 1,296,824 shares of the company’s stock, valued at $90,245,982.16. This trade represents a 4.61% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 1,707,614 shares of company stock worth $129,031,621 in the last 90 days. 11.90% of the stock is owned by company insiders.

Hedge Funds Weigh In On Rocket Lab

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in RKLB. AQR Capital Management LLC grew its holdings in Rocket Lab by 114.0% during the 1st quarter. AQR Capital Management LLC now owns 174,308 shares of the rocket manufacturer’s stock valued at $3,117,000 after buying an additional 92,849 shares in the last quarter. NewEdge Advisors LLC raised its holdings in shares of Rocket Lab by 1,812.1% during the 1st quarter. NewEdge Advisors LLC now owns 36,807 shares of the rocket manufacturer’s stock worth $658,000 after acquiring an additional 34,882 shares in the last quarter. Jones Financial Companies Lllp boosted its position in shares of Rocket Lab by 53.8% during the 1st quarter. Jones Financial Companies Lllp now owns 15,745 shares of the rocket manufacturer’s stock valued at $282,000 after acquiring an additional 5,507 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Rocket Lab by 13.3% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 773,548 shares of the rocket manufacturer’s stock valued at $13,831,000 after acquiring an additional 90,758 shares during the last quarter. Finally, Focus Partners Wealth grew its holdings in shares of Rocket Lab by 1.0% in the first quarter. Focus Partners Wealth now owns 67,584 shares of the rocket manufacturer’s stock valued at $1,206,000 after purchasing an additional 681 shares in the last quarter. 71.78% of the stock is owned by institutional investors.

Trending Headlines about Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Germany cleared Rocket Lab’s acquisition of Mynaric, removing a regulatory hurdle and improving access to optical communications supply chain and integration benefits — a catalyst that previously pushed shares sharply higher. Rocket Lab (RKLB) Stock Soars 12% as Germany Greenlights Mynaric Acquisition
• Positive Sentiment: Rocket Lab’s growing defense/business backlog (including a reported ~$190M hypersonic HASTE contract and SDA/DoD work) increases multi‑year revenue visibility and supports a constructive long‑term growth case. Does Rocket Lab’s Record Hypersonic Test Deal Redefine the Bull Case for RKLB?
• Positive Sentiment: Sector-wide optimism from reports that SpaceX confidentially filed for an IPO and the high-profile NASA Artemis II activity are lifting sentiment across space names, providing momentum tailwinds for RKLB. Planet Labs and Rocket Lab Stocks Surge after SpaceX Confidentially Files for IPO
• Neutral Sentiment: Analyst coverage is mixed: some firms highlight “significant growth potential” while others (Wells Fargo) initiated at equal‑weight with a $60 price target — creating balanced upside/downside signals rather than a clear near‑term directional driver. Rocket Lab (RKLB) Stock Faces Mixed Forecast
• Neutral Sentiment: Analyst notes and research pieces (Zacks, others) call out a $1.85B backlog and strong demand but warn of execution risks (Neutron timing, supplier constraints) — supportive for revenue outlook but risk to near‑term results. Rocket Lab’s Backlog Provides a Clear Path to 2026 Revenue Growth
• Negative Sentiment: Geopolitical fears and risk‑off headlines drove an early intraday pullback in space stocks (reports of ~6% drops in RKLB in early trading), which can pressure sentiment even as company fundamentals remain constructive. AST SpaceMobile and Rocket Lab Drop 6%: Geopolitical Fears Overshadow Catalysts
• Negative Sentiment: Rocket Lab filed a large share sale program (~$1B), which investors may view as dilution risk or prudent financing depending on execution; that ambiguity can cap near‑term upside. Prediction: Rocket Lab Could Soar if This $1 Billion Bet Pays Off

About Rocket Lab

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company’s primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company’s propulsion capabilities.